Swanson Kurtis J, Joachim Emily, Arunachalam Annamalai, Aziz Fahad, Garg Neetika, Mohamed Maha, Djamali Arjang, Redfield Robert R, Kaufman Dixon B, Odorico Jon, Mandelbrot Didier, Parajuli Sandesh
Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Division of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Transplant Direct. 2020 Feb 24;6(3):e539. doi: 10.1097/TXD.0000000000000983. eCollection 2020 Mar.
Weight change, primarily weight gain, is a common problem among solid organ transplant recipients. The incidence of weight gain or loss after successful pancreas transplant alone (PTA) and the effect on graft survival is unknown.
This was a single-center observational study among PTA recipients, transplanted at our center between January 1, 2005, and July 31, 2017, who had a functional pancreas graft for at least 1 year and documented weight change at the 1-year clinic visit.
In this cohort study of 105 PTA recipients, 28 had significant weight gain, 27 had significant weight loss, and the remaining 50 did not have significant weight change at 1-year posttransplant. When comparing the weight gain and no weight change groups, the weight gain cohort started to gain weight at 3 months posttransplant to 5 years or last follow up. Similarly, the weight loss group lost weight at 3 months posttransplant up to last follow up. Clinically significant weight gain or weight loss were not associated with uncensored or death censored graft failure in univariate regression and Kaplan-Meier survival analysis. Also, there were no significant differences between the groups in the glycated hemoglobin at last follow up.
Approximately 50% of PTA recipients had a significant weight change at 1-year posttransplant, of which 25% gained significant weight and 25% loss. There was no significant difference in graft survival due to the significant weight changes. Further research is needed in this field.
体重变化,主要是体重增加,是实体器官移植受者中常见的问题。单纯胰腺移植(PTA)成功后体重增加或减轻的发生率以及对移植物存活的影响尚不清楚。
这是一项针对PTA受者的单中心观察性研究,这些受者于2005年1月1日至2017年7月31日在我们中心接受移植,其胰腺移植物功能至少维持1年,并在1年门诊就诊时有体重变化记录。
在这项对105名PTA受者的队列研究中,28名体重显著增加,27名体重显著减轻,其余50名在移植后1年体重无显著变化。比较体重增加组和体重无变化组时,体重增加队列在移植后3个月至5年或最后一次随访期间开始体重增加。同样,体重减轻组在移植后3个月至最后一次随访期间体重减轻。在单变量回归和Kaplan-Meier生存分析中,临床上显著的体重增加或减轻与未删失或死亡删失的移植物失败无关。此外,在最后一次随访时,各组之间糖化血红蛋白没有显著差异。
约50%的PTA受者在移植后1年有显著体重变化,其中25%体重显著增加,25%体重减轻。显著的体重变化对移植物存活没有显著差异。该领域需要进一步研究。